Global S&T Development Trend Analysis Platform of Resources and Environment
DOI | 10.1126/science.abi6719 |
Partial immunity and SARS-CoV-2 mutations—Response | |
Chadi M. Saad-Roy; Sinead E. Morris; C. Jessica E. Metcalf; Michael J. Mina; Rachel E. Baker; Jeremy Farrar; Edward C. Holmes; Oliver G. Pybus; Andrea L. Graham; Simon A. Levin; Bryan T. Grenfell; Caroline E. Wagner | |
2021-04-23 | |
发表期刊 | Science
![]() |
出版年 | 2021 |
英文摘要 | Hanage and Russell conjecture [see also ([ 1 ][1])] that intermediate levels of immunity may sufficiently restrict within-host viral population size and thus limit adaptive mutations. The evolutionary model in our Research Article encompasses a wide range of scenarios, including the optimistic one Hanage and Russell propose (see scenario 1 in Fig. 4A of the Research Article). However, we also argued that uncertainties in immunodynamics, and in particular evolutionary dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), dominate our ability to project key scenarios. We therefore produced generic models in an effort to encompass this variability while providing a useful framework for considering possible future outcomes.
We would also like to clarify that the calculations for evolutionary potential in our Research Article involve only infections after natural or vaccinal immunity has waned [i.e., I S (secondary infection after waned natural immunity), I S1 (infection after waned one-dose vaccinal immunity), and I S2 (infection after waned two-dose vaccinal immunity), see Fig. 1]. Our accompanying interactive online application allows for the exploration of the effect of an even wider range of parameters on immunological and epidemiological outcomes.
We stress that the understanding of viral phylodynamics (the intersection of the epidemiological and evolutionary dynamics of pathogens) is still in its infancy, especially for novel pathogens like SARS-CoV-2. We therefore believe that exploring the resulting uncertainty is key. Understanding the dynamics of different classes of individuals experiencing infections after the waning of natural or vaccinal immunity will be crucial for teasing out drivers of viral immune escape (i.e., the ability of a virus to evolve to evade host immune factors); this is at the heart of our model. Along these lines, and as we highlight in the Research Article, an important area of future work will be to develop phylodynamic models with explicit within-host dynamics ([ 2 ][2]).
The other major source of uncertainties is in epidemiological outcomes. In their Letter, Hanage and Russell emphasize the likely epidemiological importance of widespread vaccine deployment. This echoes a conclusion of our Research Article, wherein we stress that short-term dose sparing deployment of a vaccine reduces infections and buys much time in public health planning. However, we also stressed the range of uncertainties that may modulate the longer-term outcomes of this strategy; in particular, less robust immunity could lead to more complex epidemiological and evolutionary outcomes.
1. [↵][3]1. S. Cobey,
2. D. B. Larremore,
3. Y. H. Grad,
4. M. Lipsitch
, “Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination,” preprint, Harvard University (2021); |
领域 | 气候变化 ; 资源环境 |
URL | 查看原文 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://119.78.100.173/C666/handle/2XK7JSWQ/324060 |
专题 | 气候变化 资源环境科学 |
推荐引用方式 GB/T 7714 | Chadi M. Saad-Roy,Sinead E. Morris,C. Jessica E. Metcalf,等. Partial immunity and SARS-CoV-2 mutations—Response[J]. Science,2021. |
APA | Chadi M. Saad-Roy.,Sinead E. Morris.,C. Jessica E. Metcalf.,Michael J. Mina.,Rachel E. Baker.,...&Caroline E. Wagner.(2021).Partial immunity and SARS-CoV-2 mutations—Response.Science. |
MLA | Chadi M. Saad-Roy,et al."Partial immunity and SARS-CoV-2 mutations—Response".Science (2021). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论